Summary: The board of directors of Aresa A/S appoints Carsten Meier as interim managing director of Aresa A/S

First North Announcement no. 13  2007/ August 13th, 2007


Copenhagen, August 13th, 2007

Summary: The board of directors of Aresa A/S appoints Carsten Meier as interim
managing director of Aresa A/S 

The board of directors at Aresa A/S has appointed, Chief Scientific Officer
(CSO) and founder Mr. Carsten Meier as interim managing director of Aresa A/S.
As previously announced in First North announcements #8 and #11, the board
expects to be able to announce the name of a new managing director shortly. 

At the same time Mr Carsten Meier has been elected to the board of directors of
both of the daughter companies of Aresa A/S, Aresa Biodetection ApS and Aresa
Biopharma ApS. The appointments were made following extra ordinary general
meetings in both of the companies. The boards of both of the daughter companies
appointed Ole Andersen as chairman replacing Jarne Elleholm, who has resigned
from both duties. 

The content of this message is not expected to have impact on the result for
the current financial year. 


Best regards,

Ole Andersen
Chairman
Aresa A/S


Further information can be obtained by contacting Ole Andersen, Chairman for
Aresa A/S on+45 70227747 or +45 40580214 or to the company's financial advisor
HSH Gudme Corporate Finance A/S, Morten Kjærulff, Director, +45 33449431. 

About Aresa
Aresa is a plant biotech company established in 2001 by the company's current
CSO, Carsten Meier and has origins from the Institute of Molecular Biology at
Copenhagen University. 

Aresa has developed two plant based technology platforms, BioSensor for the
detection of substances in soil, hereunder evaporation of explosives from
landmines; and BioPharma, a tool for the optimisation and production of
antibodies and proteins in plants. 

Aresa was listed on the Copenhagen OMX-First North market place in 2006. Aresa
is based at Symbion Science Park in Copenhagen and has greenhouse facilities in
the outskirts of Copenhagen and test areas in Denmark, Croatia and  Serbia.
Aresa has 16 employees, hereof 8 within research and development and 5 within
landmine operations.